Surprisingly, because of vast differences in sensitivity and specificity in detecting HF, it has been suggested that the overall cost-effectiveness of measuring serum NT-proBNP becomes comparable to that of screening for HF using the 12-lead ECG alone,25,26 due mainly to the relatively low specificity of the 12-lead ECG.26 The gene discussed is NPPB; the disease is hydrops fetalis.